PKM2 contributes to cancer metabolism
Nicholas Wong1, Diane Ojo1, Judy Yan1
1Division of Nephrology, Department of Medicine, Hamilton, Ontario, Canada; Division of Urology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Father Sean O'Sullivan Research Institute, Hamilton, Ontario, Canada; The Hamilton Center for Kidney Research, St. Joseph's Hospital, Hamilton, Ontario, Canada.
Cancer Letters
|February 11, 2014
Summary
Pyruvate kinase M2 (PKM2) is crucial for cancer metabolism. Its dimeric form fuels anabolic growth via aerobic glycolysis, while the tetrameric form generates ATP through oxidative phosphorylation, impacting tumorigenesis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cellular metabolism reprogramming is a hallmark of tumorigenesis.
- Pyruvate kinase M2 (PKM2) is a key regulator in this metabolic network.
- PKM2 exists in different oligomeric states (monomer, dimer, tetramer) influencing its enzymatic activity.
Purpose of the Study:
- To elucidate the role of PKM2 in regulating cancer cell metabolism.
- To discuss the mechanisms by which PKM2's different forms impact metabolic pathways.
- To review the current understanding of PKM2's function in tumorigenesis.
Main Methods:
- Literature review and synthesis of existing research on PKM2.
- Analysis of PKM2's enzymatic activity in different oligomeric states.
- Examination of PKM2's role in aerobic glycolysis and oxidative phosphorylation.
Main Results:
- Dimeric PKM2 promotes aerobic glycolysis, diverting glucose to anabolic processes.
- Tetrameric PKM2 enhances ATP production via oxidative phosphorylation.
- The equilibrium between PKM2 dimer and tetramer is critical for tumor development and is influenced by various factors.
Conclusions:
- PKM2's oligomeric state dictates its function in cancer metabolism.
- PKM2 dimer also influences aerobic glycolysis through transcriptional regulation.
- Understanding PKM2 regulation is vital for targeting cancer metabolism.
More Related Videos
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:53Adaptive Mechanisms in Cancer Cells
3.8K
3.8K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K